|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2600125471 |
|
最近更新日期: Date of Last Refreshed on: |
2026-05-27 11:47:46 |
|
注册时间: Date of Registration: |
2026-05-27 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
老年人主动睡眠健康管理对睡眠及其相关健康因素影响的队列研究 |
|
Public title: |
A Cohort Study on the Effect of Active Sleep Health Management on Sleep and Related Health Factors in the Elderly |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
老年人主动睡眠健康管理对睡眠及其相关健康因素影响的队列研究 |
|
Scientific title: |
A Cohort Study on the Effect of Active Sleep Health Management on Sleep and Related Health Factors in the Elderly |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
韩伟丽 |
研究负责人: |
丁罡 |
|
Applicant: |
Han Weili |
Study leader: |
Ding Gang |
|
申请注册联系人电话: Applicant telephone: |
+86 182 2623 3213 |
研究负责人电话: Study leader's telephone: |
+86 186 2106 6186 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
934759647@qq.com |
研究负责人电子邮件: Study leader's E-mail: |
xuanheyjy@shareonhealth.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
上海市浦东新区周浦镇忘忧路119号 |
研究负责人通讯地址: |
上海市浦东新区周浦镇忘忧路119号 |
|
Applicant address: |
No.119, Wangyou Road, Zhoupu Town, Pudong New District, Shanghai |
Study leader's address: |
No.119, Wangyou Road, Zhoupu Town, Pudong New District, Shanghai |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
上海玄合元门诊部 |
||
|
Applicant's institution: |
Shanghai Xuanheyuan Outpatient Department |
||
|
研究负责人所在单位: |
上海玄合元门诊部 |
||
|
Affiliation of the Leader: |
Shanghai Xuanheyuan Outpatient Department |
||
|
是否获伦理委员会批准: |
是/Yes |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
XHYSL[2025]-005 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
上海玄合元门诊部医学伦理委员会 |
||
|
Name of the ethic committee: |
Medical Ethics Committee of Shanghai Xuanheyuan Outpatient Department |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2026-01-22 00:00:00 |
||
|
伦理委员会联系人: |
郑毓芳 |
||
|
Contact Name of the ethic committee: |
Zheng Yufang |
||
|
伦理委员会联系地址: |
上海市浦东新区周浦镇忘忧路119号 |
||
|
Contact Address of the ethic committee: |
No.119, Wangyou Road, Zhoupu Town, Pudong New District, Shanghai |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 189 1609 3526 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
xuanheyjy@shareonhealth.com |
|
研究实施负责(组长)单位: |
上海玄合元门诊部 |
||||||||||||||||||||||
|
Primary sponsor: |
Shanghai Xuanheyuan Outpatient Department |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
上海市浦东新区周浦镇忘忧路119号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
No.119, Wangyou Road, Zhoupu Town, Pudong New District, Shanghai |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
本研究经费总额为人民币50万元,由玄合医疗集团提供。 |
||||||||||||||||||||||
|
Source(s) of funding: |
The total funding for this study amounts to RMB 500,000, provided by Xuanhe Medical Group. |
||||||||||||||||||||||
|
Target disease: |
none |
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
观察性研究 |
||||||||||||||||||||||
|
Study type: |
Observational study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
连续入组 |
||||||||||||||||||||||
|
Study design: |
Sequential |
||||||||||||||||||||||
|
研究目的: |
1.通过横断面研究了解老年人群睡眠障碍的发生率以及“主动健康意识”与“睡眠健康”及其主要健康指标的关联性; 2.建立社区老年人睡眠障碍筛查及睡眠健康管理队列,评价“主动睡眠健康管理模式”对老年人睡眠及其相关健康因素改善的影响; 3.通过研究形成社区老年人主动睡眠健康管理应用平台,并在平台上构建社区老年人数字化睡眠障碍评估管理档案; 4.建立老年人睡眠健康生物样本库为后续进一步开展衰老相关研究提供基础。 |
||||||||||||||||||||||
|
Objectives of Study: |
1.To investigate the prevalence of sleep disorders in the elderly population and the association between "active health awareness" and "sleep health" as well as its primary health indicators through cross-sectional studies; 2.To establish a community-based cohort for sleep disorder screening and sleep health management in the elderly, and to evaluate the impact of the "active sleep health management model" on improving sleep and related health factors in the elderly; 3.To develop an application platform for active sleep health management in the elderly through research, and to construct a digital sleep disorder assessment and management archive for the elderly on the platform; 4.To establish a biological sample bank for sleep health in the elderly to provide a foundation for further aging-related research. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
1.参与者年龄>=60岁,符合中国对“老年人”的定义,也符合《中国健康老年人标准》的适用人群,性别不限。 2.有使用智能设备(包括但不仅限于智能手机、可穿戴设备等)的能力。 3.签署知情同意书(参与横断面研究和队列研究的参与者分别签署知情同意书)。 4.参与者在研究区域内有稳定的居住地址,且计划在未来1年内不搬离,以方便研究团队进行定期随访和数据收集。 5.参与者愿意将日常的睡眠及睡眠相关健康数据主动传递至健康管理应用平台。 |
||||||||||||||||||||||
|
Inclusion criteria |
1.Participants aged >=60 years, meeting the definition of "elderly" in China and the applicable population of the "China Healthy Elderly Standards", with no gender restriction. 2.Ability to use smart devices (including but not limited to smartphones, wearables, etc.). 3.Sign the informed consent form (participants in cross-sectional studies and cohort studies shall sign the informed consent form respectively). 4.Participants must have a stable residential address within the study area and plan not to relocate within the next 1 year to facilitate regular follow-up and data collection by the research team. 5.Participants are willing to voluntarily share their daily sleep and sleep-related health data with the health management application platform. |
||||||||||||||||||||||
|
排除标准: |
1.参与者有严重的疾病(如终末期肾病、重度心脏病、肝功能衰竭、恶性肿瘤等),或近3-6个月内发生过急性心肌梗死、脑卒中等严重心脑血管事件。 2.参与者有严重的精神健康问题或严重的认知障碍,可能无法理解研究内容或遵守研究要求。 3.参与者存在语言或文化障碍,导致无法有效理解和参与研究过程。 4.参与者存在严重视力问题无法使用智能设备或参与研究过程。 |
||||||||||||||||||||||
|
Exclusion criteria: |
1.Participants with severe diseases (e.g., end-stage renal disease, severe heart disease, liver failure, malignant tumors, etc.), or those who have experienced serious cardiovascular events such as acute myocardial infarction (AMI) or stroke within the past 3-6 months. 2.Participants with severe mental health conditions or significant cognitive impairments may be unable to comprehend the study content or comply with the study requirements. 3.Participants have language or cultural barriers that prevent effective understanding and participation in the research process. 4.Participants with severe visual impairment were ineligible for using smart devices or participating in the study process. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2026-05-31 00:00:00至 To 2028-06-30 00:00:00 |
征募观察对象时间: Recruiting time: |
从From 2026-05-31 00:00:00 至 To 2028-06-30 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
无 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
no |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
不公开/Private |
|
盲法: |
|
|
Blinding: |
|
是否共享原始数据: IPD sharing |
No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
无 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
None |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
电子采集和管理系统 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Electronic Data Capture, EDC |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |